Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis.
about
Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.Cell surface-specific N-glycan profiling in breast cancerComparing MALDI-MS, RP-LC-MALDI-MS and RP-LC-ESI-MS glycomic profiles of permethylated N-glycans derived from model glycoproteins and human blood serumA comparison of N-glycan profiles in human plasma and vitreous fluid.Changes to serum sample tube and processing methodology does not cause Intra-Individual [corrected] variation in automated whole serum N-glycan profiling in health and diseaseIdentification of 34 N-glycan isomers in human serum by capillary electrophoresis coupled with laser-induced fluorescence allows improving glycan biomarker discovery.Specific N-glycans of Hepatocellular Carcinoma Cell Surface and the Abnormal Increase of Core-α-1, 6-fucosylated Triantennary Glycan via N-acetylglucosaminyltransferases-IVa Regulation.Analytical glycobiology at high sensitivity: current approaches and directionsN-glycome Profile Levels Relate to Silent Brain Infarcts in a Cohort of Hypertensives.GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics.Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants.High-sensitivity analytical approaches for the structural characterization of glycoproteins.Impaired N-linked glycosylation of uptake and efflux transporters in human non-alcoholic fatty liver disease.LC-MS/MS of permethylated N-glycans derived from model and human blood serum glycoproteins.Glycosylation site occupancy in health, congenital disorder of glycosylation and fatty liver disease.Impact of elevation of total bilirubin level and etiology of the liver disease on serum N-glycosylation patterns in mice and humans.N-glycan based models improve diagnostic efficacies in hepatitis B virus-related hepatocellular carcinoma.
P2860
Q30432576-4B3514CC-EDF9-4B1C-B563-923B93B3B3CEQ31137153-C2CC55B2-265B-4D28-AE5B-3BBB355BAE2AQ34074809-23EDF54F-957E-42B3-8825-DDFB5EBE8AC0Q35184247-F386AFF3-6EE4-4B33-86AC-692FC816DB75Q35241750-491CD64A-CA40-4ED2-B899-B2CD1DBEE409Q35262822-2D8228EF-8E43-449F-98B1-88949CB50863Q36249639-A95D9585-13AA-4738-BF8F-12962FBE1B44Q36651493-29B8AA7F-E6A5-40C0-88D5-71C231C4AAA6Q36836256-AA6D2285-BFAE-4086-AFC4-A8A883B51D7EQ37210696-33FD30C0-20A3-4043-A0CD-E5DE61BCFF5CQ37678208-B1477BB4-AF5B-423E-BB53-522B76E7C485Q37712517-68A9C565-08E0-48FE-864A-0D4D958FEFDDQ39015474-8774F413-70C5-4AA8-B733-7921D8522216Q39934984-A6F1241E-79FF-43D4-A7A3-DEA5F2EA6B67Q41388809-464A77EC-7810-45CE-B195-0D01C342BF04Q43199850-96B9234D-EF3D-45E0-8C3B-A2A3ABC10720Q43244550-6D41F43A-F34F-4871-A1AF-C2501585B6A2
P2860
Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Serum protein N-glycans profil ...... nonalcoholic steatohepatitis.
@en
Serum protein N-glycans profil ...... nonalcoholic steatohepatitis.
@nl
type
label
Serum protein N-glycans profil ...... nonalcoholic steatohepatitis.
@en
Serum protein N-glycans profil ...... nonalcoholic steatohepatitis.
@nl
prefLabel
Serum protein N-glycans profil ...... nonalcoholic steatohepatitis.
@en
Serum protein N-glycans profil ...... nonalcoholic steatohepatitis.
@nl
P2093
P356
P1476
Serum protein N-glycans profil ...... r nonalcoholic steatohepatitis
@en
P2093
Claude Libert
Cuiying Chen
Hans Van Vlierberghe
Hemda Schmilovitz-Weiss
Jaqueline Sulkes
Marisa Halpern
Marius Braun
Maya Cohen
Orit Pappo
Ran Tur-Kaspa
P304
P356
10.1021/PR800656E
P577
2009-02-01T00:00:00Z